Canada markets closed

IGC Pharma, Inc. (IGC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.5200+0.0120 (+2.36%)
At close: 04:00PM EDT
0.5023 -0.02 (-3.40%)
After hours: 07:58PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Cash flows from operating activities
Net Income
-10,805
-11,506
-15,016
-8,811
Depreciation & amortization
638
657
651
478
Stock based compensation
1,974
2,843
2,197
658
Change in working capital
1,874
794
2,536
-3,294
Accounts receivable
40
5
50
-42
Inventory
1,114
897
1,930
-1,233
Accounts Payable
92
-451
504
-287
Other working capital
-6,913
-7,666
-8,233
-12,392
Other non-cash items
-
-
-430
-
Net cash provided by operating activites
-6,251
-7,047
-7,462
-10,800
Cash flows from investing activities
Investments in property, plant and equipment
-662
-619
-771
-1,592
Purchases of investments
-
-154
0
-149
Sales/Maturities of investments
-
-
0
5,128
Net cash used for investing activites
-192
-235
-742
3,387
Cash flows from financing activities
Debt repayment
-3
-3
-3
-50
Common stock issued
2,860
103
4,145
14,158
Net cash used privided by (used for) financing activities
2,857
100
4,142
14,688
Net change in cash
-3,597
-7,264
-4,088
7,290
Cash at beginning of period
6,623
10,460
14,548
7,258
Cash at end of period
3,037
3,196
10,460
14,548
Free Cash Flow
Operating Cash Flow
-6,251
-7,047
-7,462
-10,800
Capital Expenditure
-662
-619
-771
-1,592
Free Cash Flow
-6,913
-7,666
-8,233
-12,392